Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct 22;5(10):e004188.
doi: 10.1161/JAHA.116.004188.

Treatment Intensification for Hypertension in US Ambulatory Medical Care

Lin Mu  1 , Kenneth J Mukamal  2
Affiliations

Treatment Intensification for Hypertension in US Ambulatory Medical Care

Lin Mu et al. J Am Heart Assoc. .

Abstract

Background: Hypertension is widely prevalent yet remains uncontrolled in nearly half of US hypertensive adults. Treatment intensification for hypertension reduces rates of major cardiovascular events and all-cause mortality, but clinical inertia remains a notable impediment to further improving hypertension control. This study examines the likelihood and determinants of treatment intensification with new medication in US ambulatory medical care.

Methods and results: Using the nationally representative National Ambulatory Medical Care Survey (2005-2012) and National Hospital Ambulatory Medical Care Survey (2005-2011), we identified adult primary care visits with diagnosed hypertension and documented blood pressure exceeding goal targets and assessed the weighted prevalence and odds ratios of treatment intensification by initiation or addition of new medication. Approximately 41.7 million yearly primary care visits (crude N: 14 064, 2005-2012) occurred among US hypertensive adults with documented blood pressure ≥140/90 mm Hg, where treatment intensification may be beneficial. However, only 7.0 million of these visits (95% confidence interval 6.2-7.8 million) received treatment intensification with new medication, a weighted prevalence of 16.8% (15.8% to 17.9%). This proportion was consistently low and decreased over time. This decline was largely driven by decreasing medication initiation levels among patients on no previous hypertension medications from 31.8% (26.0% to 38.4%) in 2007 to 17.4% (14.0% to 21.4%) in 2012, while medication addition levels remained more stable over time.

Conclusions: US hypertensive adults received treatment intensification with new medication in only 1 out of 6 primary care visits, a fraction that is declining over time. A profound increase in intensification remains a vast opportunity to maximally reduce hypertension-related morbidity and mortality nationwide.

Keywords: blood pressure; hypertension medication; medication addition; medication initiation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Prevalence of hypertension treatment intensification in the United States 2005–2012.
Figure 2
Figure 2
Weighted prevalence of hypertension treatment intensification at different systolic blood pressure levels by patient characteristics in NAMCS and NHAMCS visits 2005–2012. Data are color‐coded based on weighted prevalence from the lowest (red) to the highest (green). The minimum (6.9%) and the maximum (38.4%) are indicated with dark squares. Numbers are calculated among adult primary care visits with diagnosed hypertension and measured blood pressure at or above listed systolic blood pressure levels. CHIP indicates Children's Health Insurance Program; NAMCS, National Ambulatory Medical Care Survey; NHAMCS, National Hospital Ambulatory Medical Care Survey.
See this image and copyright information in PMC

Comment in

  • Hypertension Management: Ripe for Disruption.
    Hess PL, Michael Ho P. Hess PL, et al. J Am Heart Assoc. 2016 Oct 22;5(10):e004681. doi: 10.1161/JAHA.116.004681. J Am Heart Assoc. 2016. PMID: 27792663 Free PMC article. No abstract available.

References

    1. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. NCHS data brief, no 133. Hyattsville, MD: National Center for Health Statistics. 2013. - PubMed
    1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després J‐P, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee . Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131:e29–e322. - PubMed
    1. Yoon SS, Gu Q, Nwankwo T, Wright JD, Hong Y, Burt V. Trends in blood pressure among adults with hypertension: United States, 2003 to 2012. Hypertension. 2015;65:54–61. - PMC - PubMed
    1. James PA, Oparil S, Carter BL, Cushman WC, Dennison‐Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E. 2014 evidence‐based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–520. - PubMed
    1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–497. - PubMed

Substances

LinkOut - more resources